High-dose ethosuximide for epilepsy in Angelman syndrome: implication of GABA(A) receptor subunit.
Sugiura
C
C
Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Tottori, Japan. dcn@grape.med.tottori-u.ac.jp
Ogura
K
K
Ueno
M
M
Toyoshima
M
M
Oka
A
A
D017204:Angelman Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D000927:Anticonvulsants / Q000008:administration & dosage*; D004569:Electroencephalography / Q000187:drug effects; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005013:Ethosuximide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D011963:Receptors, GABA-A / Q000502:physiology*
D000927:Anticonvulsants; D011963:Receptors, GABA-A; D005013:Ethosuximide